Clomid

(redirected from clomiphene citrate)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.

Clomid

(klō`mĭd): see fertility drugfertility drug,
any of a variety of substances used to increase the possibility of conception and successful pregnancy. Different methods are used to correct or circumvent the many different functional disorders of both males and females that can interfere with conception and
..... Click the link for more information.
.
Mentioned in ?
References in periodicals archive ?
Clomiphene citrate has been the principal drug used for induction of ovulation in women with polycystic ovarian syndrome (PCOS).
N-acetyl-cysteine is a novel adjuvant to clomiphene citrate in clomiphene citrate-resistant patients with polycystic ovary syndrome.
Comparison of letrozole with continuous gonadotropins and clomiphene-gonadotropin combination for ovulation induction in 1387 PCOS women after clomiphene citrate failure: a randomized prospective clinical trial.
This approach is easy to use in clinical practice and constitutes an appealing alternative to clomiphene citrate, considering that metformin has well-established long-term safety, good tolerability, and that it acts on insulin resistance," Dr.
The women were evaluated and counseled by the consultants for IUI treatment either with Clomiphene Citrate (clomid), (OBS Pharma, Pakistan) and gonadotrophins (HMG, Massone Pharma, Argentina) or Letrozole (Novartis Pharma, Australia) and HMG.
CRVO is not often seen by gynaecologists, but they should be aware of the condition in fertility patients undergoing induction of ovulation, especially with clomiphene citrate.
Supplementation of clomiphene citrate cycles with Cimicifuga racemosa or ethinyl oestradiol - a randomized trial.
Women with ovulatory dysfunction undergoing ovarian stimulation with clomiphene citrate for intrauterine insemination may benefit from administration of human chorionic gonadotropin.
A combination of clomiphene citrate and human menopausal gonadotropin was administered to both groups to achieve ovulation.
In a separate analysis of 184 women with World Health Organization (WHO) Group II anovulatory infertility who failed to ovulate or conceive on clomiphene citrate and were randomized to receive either MENOPUR(R) or Gonal-f treatment in a low-dose step-up protocol, results demonstrated that treatment with MENOPUR(R) is associated with equivalent ovulation and pregnancy rates compared with Gonal-f.
Our second product candidate, Androxal([R]) is a single isomer of clomiphene citrate and is an orally active proprietary small molecule compound.
Fifty-eight subfertile women (mean age, 32 years) undergoing ovulation induction with clomiphene citrate or gonadotropins were randomly assigned to receive a multiple micronutrient supplement (MMN) or folic acid alone (dose not specified).